SCHEMBL7655431

SCHEMBL7655431

NC(=O)OC(Cc1ccccc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.58
PKM P14618 2/20 0.49
SRR Q9GZT4 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ALPI P09923 1/20 0.48
PTGS1 P23219 1/20 0.48
XIAP P98170 1/20 0.48
SLC7A5 Q01650 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27608757 0.90 SOAT1 (0.51) EPHX1PKMCYP1A2CYP2D6SMN1; SMN2
SCHEMBL4745769 0.86 GRIA2 (0.47) EPHX1PKMCYP1A2CYP2D6SMN1; SMN2
SCHEMBL27733213 0.86 MAOA (0.45) EPHX1PKMCYP1A2CYP2D6SMN1; SMN2
SCHEMBL11845837 0.85 EPHX1 (0.52) EPHX1PKMSRRCYP1A2CYP2D6
SCHEMBL27726511 0.85 EPHX1 (0.52) EPHX1PKMSRRCYP1A2CYP2D6
SCHEMBL9067637 0.85 EPHX1 (0.52) EPHX1PKMSRRCYP1A2CYP2D6
SCHEMBL28951569 0.85 IDO1 (0.53)
SCHEMBL7511466 0.83 CYP1A2 (0.50) PKMCYP1A2CYP2D6SMN1; SMN2NPSR1
SCHEMBL21523061 0.83 CYP1A2 (0.50) PKMCYP1A2CYP2D6SMN1; SMN2NPSR1
SCHEMBL28500481 0.83 GSR (0.51) PKMCYP1A2CYP2D6SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6319310-B1 FOR ACOUSTIC INK JET PRINTING; TRANSPARENCY, GLOSS, CREASE RESISTANCE XEROX CORPORATION 2001-11-20 US claimed
US-6288141-B1 Ink compositions XEROX CORPORATION 2001-09-11 US claimed
US-6132499-A Inks XEROX CORPORATION (US) 2000-10-17 US claimed
US-6071333-A Ink compositions XEROX CORPORATION (US) 2000-06-06 US claimed
US-6045607-A FIRST AND SECOND SOLID CARBAMATES WITH A DISSIMILAR MELTING POINTS; LIGHTFASTNESS COMPONENT; A LIGHTFASTNESS ANTIOXIDANTS, AND A COLORANT; USEFUL FOR ACOUSTIC INK PRINTING XEROX CORPORATION (US) 2000-04-04 US claimed
CN-115667215-A Broad-spectrum antiviral medicine for resisting coronavirus 堪萨斯州立大学研究基金会 2023-01-31 CN disclosed
CN-112159401-B Biased agonist and medical application thereof 中国人民解放军军事科学院军事医学研究院 2022-06-03 CN disclosed
CN-112159401-A Biased agonist and medical application thereof 中国人民解放军军事科学院军事医学研究院 2021-01-01 CN disclosed
US-6334890-B1 COMPOSITION COMPRISED OF OXAZOLINE COMPOUND WITH SPECIFIED MELTING POINT AND ACOUSTIC LOSS VALUE, LONG CHAIN CARBAMATE, ALCOHOL COMPOUND, LIGHTFASTNESS COMPONENT, LIGHTFASTNESS ANTIOXIDANT, COLORANT XEROX CORPORATION 2002-01-01 US disclosed
US-6319310-B1 FOR ACOUSTIC INK JET PRINTING; TRANSPARENCY, GLOSS, CREASE RESISTANCE XEROX CORPORATION 2001-11-20 US disclosed
US-6288141-B1 Ink compositions XEROX CORPORATION 2001-09-11 US disclosed
US-6187082-B1 COMPOSITION COMPRISED OF THIOUREA AND INK CARBAMATE, EACH WITH SPECIFIED MELTING POINT AND ACOUSTIC-LOSS VALUE, LIGHTFASTNESS COMPONENT, LIGHTFAST ANTIOXIDANT, COLORANT XEROX CORPORATION 2001-02-13 US disclosed
US-6132499-A Inks XEROX CORPORATION (US) 2000-10-17 US disclosed
US-6110265-A Ink compositions XEROX CORPORATION (US) 2000-08-29 US disclosed
US-6106601-A MIXTURE CONTAINING OXAZOLINE AND THIOUREA COMPOUNDS XEROX CORPORATION (US) 2000-08-22 US disclosed
US-6096125-A Ink compositions XEROX CORPORATION (US) 2000-08-01 US disclosed
US-6071333-A Ink compositions XEROX CORPORATION (US) 2000-06-06 US disclosed
US-6066200-A COMPRISING A SOLID UREA COMPOUND, AN ALCOHOL, A LIGHTFASTNESS COMPONENT, A LIGHTFAST ANTIOXIDANT, AND A COLORANT XEROX CORPORATION (US) 2000-05-23 US disclosed
US-6045607-A FIRST AND SECOND SOLID CARBAMATES WITH A DISSIMILAR MELTING POINTS; LIGHTFASTNESS COMPONENT; A LIGHTFASTNESS ANTIOXIDANTS, AND A COLORANT; USEFUL FOR ACOUSTIC INK PRINTING XEROX CORPORATION (US) 2000-04-04 US disclosed